Mr. David Alan Zimbrick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-1554 |
Dr. Jwan M Mustafa, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-1540 |
Dr. Mark S Foster, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-1534 |
Christina Marie Odens, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-1554 Fax: 605-245-2384 |
Dr. Jacquie Roth Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Highway 34 & 47, Fort Thompson, SD 57339 Phone: 605-245-1503 |
Michelle Duana Tuohy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-2285 Fax: 605-245-2384 |
Kyle Weiss, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-1534 |
News Archive
Researchers at EMBL's European Bioinformatics Institute (EMBL-EBI) have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry (MS) experiments.
Carriage Services, Inc. today announced that it has updated its "Company & Investment Profile,".Carriage's updated Company & Investment Profile includes updated discussions of Carriage's business, operating and growth strategies, historical financial information, financial outlook and more.
A single dose of buckwheat honey before bedtime provided the greatest relief from cough and sleep difficulty compared with no treatment and an over-the-counter cough medicine in children with upper respiratory tract infections, according to a report in the December issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Myostatin, a protein that blocks muscle growth, has shown promising results as a potential therapeutic target for treating muscular dystrophy in animal studies, where its inhibition led to increased muscle mass and strength.
The site, which is supposed to make transparent payments between drugmakers and physicians, is slated to be made public by Sept. 30. But as the deadline nears, the pharmaceutical industry is pressing the Centers for Medicare & Medicaid Services to be more transparent in explaining what's going on with the database.
› Verified 8 days ago